GW Pharmaceuticals, Otsuka Cancer-Pain Drug Misses Primary Endpoint

GW Pharmaceuticals PLC and Otsuka Pharmaceutical Development and Commercialization Inc. said Thursday that a potential treatment for cancer pain missed its primary endpoint in a late-stage trial.



from WSJ.com: US Business http://ift.tt/1w2Lu7e

via IFTTT